CO5280093A1 - Metodos de tratamiento - Google Patents

Metodos de tratamiento

Info

Publication number
CO5280093A1
CO5280093A1 CO01029288A CO01029288A CO5280093A1 CO 5280093 A1 CO5280093 A1 CO 5280093A1 CO 01029288 A CO01029288 A CO 01029288A CO 01029288 A CO01029288 A CO 01029288A CO 5280093 A1 CO5280093 A1 CO 5280093A1
Authority
CO
Colombia
Prior art keywords
alkyl
group
het
cycloalkyl
alkynyl
Prior art date
Application number
CO01029288A
Other languages
English (en)
Spanish (es)
Inventor
Robert Well
Danbiel Frank Veber
Ru-Maxwell Yu
Scott Kevon Thompson
Dennis Shinji Yamashita
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of CO5280093A1 publication Critical patent/CO5280093A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CO01029288A 2000-04-18 2001-04-16 Metodos de tratamiento CO5280093A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19771700P 2000-04-18 2000-04-18

Publications (1)

Publication Number Publication Date
CO5280093A1 true CO5280093A1 (es) 2003-05-30

Family

ID=22730469

Family Applications (1)

Application Number Title Priority Date Filing Date
CO01029288A CO5280093A1 (es) 2000-04-18 2001-04-16 Metodos de tratamiento

Country Status (5)

Country Link
EP (1) EP1303281A4 (fr)
JP (1) JP2003531122A (fr)
AU (1) AU2001253560A1 (fr)
CO (1) CO5280093A1 (fr)
WO (1) WO2001078734A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1401453A4 (fr) * 2001-05-17 2005-04-06 Smithkline Beecham Corp Inhibiteurs de protease
AU2003273697A1 (en) * 2002-10-08 2004-05-04 Merck Frosst Canada Ltd 4-amino-azepan-3-one compounds as cathepsin k inhibitors useful in the treatment of osteoporosis
WO2009087379A2 (fr) 2008-01-09 2009-07-16 Amura Therapeutics Limited Composés

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200101869T2 (tr) * 1998-12-23 2002-01-21 Smithkline Beecham Corporation Proteaz İnhibitörleri.
EP1233771A4 (fr) * 1999-11-10 2003-05-14 Smithkline Beecham Corp Inhibiteurs de protease
AU1474801A (en) * 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
EP1231921A4 (fr) * 1999-11-10 2004-06-23 Smithkline Beecham Corp Inhibiteurs de proteases
JP2003513922A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
JP2003513928A (ja) * 1999-11-10 2003-04-15 スミスクライン・ビーチャム・コーポレイション プロテアーゼ阻害剤
WO2001034565A2 (fr) * 1999-11-10 2001-05-17 Smithkline Beecham Corporation Inhibiteurs de protease
AU1474701A (en) * 1999-11-10 2001-06-06 Smithkline Beecham Corporation Protease inhibitors
US7071184B2 (en) * 2000-03-21 2006-07-04 Smithkline Beecham Corporation Protease inhibitors

Also Published As

Publication number Publication date
WO2001078734A1 (fr) 2001-10-25
AU2001253560A1 (en) 2001-10-30
EP1303281A1 (fr) 2003-04-23
JP2003531122A (ja) 2003-10-21
EP1303281A4 (fr) 2006-02-15

Similar Documents

Publication Publication Date Title
ES2102154T3 (es) Inhibicion de trombina.
ES2141174T3 (es) 4-arilmetiloximetil piperidinas como antagonistas de taquiquinina.
AR057810A1 (es) Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo y composicion farmaceutica
AR065772A1 (es) Compuestos de indolobenzazepina para el tratamiento de la hepatitis c. composiciones farmaceuticas.
AR016667A1 (es) Uso de una combinacion de un antiestrogeno mas progestina para la preparacion de un medicamento util para proveer la anticoncepcion y un kit deanticonceptivos adaptados para la administracion oral diaria
RU2005105576A (ru) Производные плевромутилина в качестве противомикроюных средств
ATE189601T1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
ES2101449T3 (es) Inhibicion de la seborrea y el acne.
ES2119094T3 (es) Inhibicion de la hemorragia uterina disfuncional.
KR950010891A (ko) 내성 종양을 치료하는 방법
ATE369348T1 (de) Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie
CO5280088A1 (es) Inhibidores de proteasa
CO5280093A1 (es) Metodos de tratamiento
CO5140099A1 (es) Ciertas caprolactamas sustituidas, composiciones farmaceuticas que las contienen, y su uso en el tratamiento de tumores
CO5271679A1 (es) Inhibidores de proteasa 7-14 miembros
CO5180541A1 (es) Inhibidores de proteasa del tipo de 1,3-diaminocetonas con anillo de 8-14 miembros
DK1294732T3 (da) Ruthenium (II)-forbindelser til anvendelse i cancerterapi
DE60104435D1 (en) 2-thiocarbamoyloxy- und 2-carbamoyloxy-derivate von cyclopentyl-heptan(en)säure als therapeutische mittel
CO5271703A1 (es) Compuestos quimicos
DE60110233D1 (de) Neue n-(2-phenyl-3-aminopropyl)naphtamide
ES2172436B1 (es) Derivados de indolilpiperidina como agentes antihistaminicos y antialergicos.
PT769945E (pt) Metodos para cicratizacao ossea e consolidacao de fracturas
AR010289A1 (es) Derivados de piperidina, procedimiento para su preparacion, formulaciones farmaceuticas que contienen los derivados y su uso en el tratamiento dedesordenes psicoticos
CO5280091A1 (es) Inhibidores de proteasas
ATE278403T1 (de) Verfahren zur inhibierung von katarakten

Legal Events

Date Code Title Description
FC Application refused